The Personalized Medicine campaign aims to unite industry leaders to educate the general public on the benefits of personalized medicine by closing knowledge gaps and highlighting its advancement in Canada.
CanPath: Canada’s Population Platform for Personalized Medicine
Personalized medicine has tremendous potential to improve patient care by tailoring medical interventions to an individual’s unique genetic makeup and life history.
When it comes to medicine, one size does not fit all. Treatments and prevention strategies that help some are ineffective for others.
Pharmacogenetic testing is changing how medications are prescribed and taking away much of the guesswork, especially for mental health and pain medications.
Pentavere’s DARWEN™ dramatically accelerates discovery of insights buried in hard-to-access clinical text to help healthcare providers make better treatment decisions
The future of medicine will be personal.
With pharmacogenomic testing, pharmacists can help identify the right medication for a patient based on their DNA.
By focusing on building companies, building ecosystems, and building talent, we will realize our shared vision of Canadian life sciences leading the world.
Imagine a future where we can tailor disease prevention, diagnosis and treatment to individual patients, based on a deep understanding of their genetic and molecular profile.